Suchergebnisse - "PCSK9 inhibitors"

PubPharm (77)

1

Evolocumab (Repatha®) : new therapy ofhypercholesterolaemia for secondary prevention of atherosclerotic disease

enthalten in: Revue medicale de Liege | 2023

von Scheen, A. | Wallemacq, C. | Lancellotti, P.

2

Primäre Fettstoffwechselstörungen – Stellenwert in aktuellen Dyslipidämieleitlinien und therapeutische Innovationen

enthalten in: Die innere Medizin | 2023

von Klose, G. | Gouni-Berthold, I. | März, W.

3

An Explainable Machine-Learning Model to Analyze the Effects of a PCSK9 Inhibitor on Thrombolysis in STEMI Patients

enthalten in: Journal of medical and biological engineering | 2023

von Zhao, P. | Zhou, J. | Liu, C. | +5

4

Can proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors regress coronary atherosclerotic plaque? A systematic review and meta-analysis

enthalten in: American journal of translational research | 2023

von Wu, Z. | Gao, L. | Lin, Z.

5

Inclisiran (Leqvio®), a potent cholesterol-lowering agent by inhibiting PCSK9 using small interfering RNA-based innovative therapy

enthalten in: Revue medicale de Liege | 2022

von Scheen, A. | Wallemacq, C. | Lancellotti, P.

6

Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 European Society of Cardiology Congress

enthalten in: Current atherosclerosis reports | 2022

von Hermel, M. | Pelter, M. | Jordan, T. | +5

7

Hyperlipidemia patients carrying LDLR splicing mutation c.1187-2A>G respond favorably to rosuvastatin and PCSK9 inhibitor evolocumab

enthalten in: Molecular genetics and genomics | 2022

von Zhang, X. | Liu, Q. | Zhang, H. | +9

8

Moderne Lipidsenker – ein Mittel gegen das Problem der Unterversorgung?

enthalten in: Die innere Medizin | 2022

von Katzmann, J. | Laufs, U.

9

PCSK9 Inhibitors in Real-world Practice: Analysis of Data from 314 Patients and 2 Years of Experience in a Center of Preventive Cardiology

enthalten in: Current atherosclerosis reports | 2022

von Altschmiedová, T. | Todorovová, V. | Šnejdrlová, M. | +2

10

Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany

enthalten in: Cardiovascular drugs and therapy | 2022

von Michaeli, D. | Michaeli, J. | Boch, T. | +1

1
2
3
4
5
6
7
8
Nächster »
[8]